Lundbeck chairman demands change: "We can't live with this"
Years of work developing new treatments at Lundbeck has so far come to nothing. This has led chairman Lars Rasmusssen to demand visible results, even though CEO Deborah Dunsire has essentially had to restart development work since she joined the firm in 2018.
by Benjamin Werner Christensen, translated by catherine brett
Chairman of the board at Lundbeck Lars Rasmussen is piling on the pressure by criticizing the company in the middle of a share price fiasco, while a growth crisis looms on the horizon.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
New Lundbeck candidate to kick off R&D division
For subscribers
